(State or other jurisdiction of incorporation) | (Commission File Number) | (IRS Employer Identification No.) |
, | , | |||||||||||||||||||
(Address of principal executive offices) | (Zip Code) |
Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions (see General Instruction A.2. below): | ||||||||
Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425) | ||||||||
Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12) | ||||||||
Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b)) | ||||||||
Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c)) |
Title of each class | Trading Symbol | Name of each exchange on which registered | ||||||
(Global Select Market) |
Indicate by check mark whether the registrant is an emerging growth company as defined in as defined in Rule 405 of the Securities Act of 1933 (§230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§240.12b-2 of this chapter). | ||||||||||||||
Emerging growth company | ||||||||||||||
If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐ |
(d) | Exhibits. |
Second Amendment to the ICU Medical, Inc. Executive Severance Plan | |||||
104 | Cover Page Interactive Data File (the instance document does not appear in the Interactive Data File because its XBRL tags are embedded within the Inline XBRL document) |
ICU MEDICAL, INC. | ||||||||||||||||||||
Date: January 3, 2023 | By: | /s/ Brian M. Bonnell | ||||||||||||||||||
Brian M. Bonnell | ||||||||||||||||||||
Chief Financial Officer |
Cover Page |
Dec. 30, 2022 |
---|---|
Cover [Abstract] | |
Document Type | 8-K |
Document Period End Date | Dec. 30, 2022 |
Entity Incorporation, State or Country Code | DE |
Entity File Number | 001-34634 |
Entity Tax Identification Number | 33-0022692 |
Entity Address, Address Line One | 951 Calle Amanecer |
Entity Address, City or Town | San Clemente |
Entity Address, State or Province | CA |
Entity Address, Postal Zip Code | 92673 |
City Area Code | 949 |
Local Phone Number | 366-2183 |
Written Communications | false |
Soliciting Material | false |
Pre-commencement Tender Offer | false |
Pre-commencement Issuer Tender Offer | false |
Title of 12(b) Security | Common stock, par value $0.10 per share |
Trading Symbol | ICUI |
Security Exchange Name | NASDAQ |
Entity Emerging Growth Company | false |
Entity Registrant Name | ICU MEDICAL INC/DE |
Amendment Flag | false |
Entity Central Index Key | 0000883984 |
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end
H!PAOE2-[S7^O#F!MQOOS'^Z"7T(\QM[\V]@-B19 M#8S('8$4V%18*-O;99=H>G=4G9?,O\\[J=R8J/FL7DYCY9J>KH V+U1Z/IT_ MLR-_R*7K;69FP""(<(\+6Q?LU;*N#K./X\#+>E6P8O]5RJON?$J'#(C*22H MH/A
E0U ,/\Z+I#6 8ZPSN:#D(E ^\1N
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MM]4AVCS:6XW30%0T6.JI_:QZUWNHHOXV2= 3> \IB=,Q=X6PC64'-(R2K
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M\C*:O$U$@\#S0O[\ID_A!
ME